FAQ
Log In
Wednesday 22nd March 2017

Semaglutide Articles

1

Experimental drug could cut heart events in diabetics

19th September 2016

Study reveals experimental drug, semaglutide, reduces major cardiovascular events by 26%.

Read All ►

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2017